Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 13/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 8/20 | 0.50 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.45 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.45 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.43 |
| ▸ | GGT1 | P19440 | 2/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL21494996 | 0.78 | GRIK1 (0.48) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL27866701 | 0.75 | GRIK1 (0.50) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL7044236 | 0.75 | GRIK1 (0.50) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL7768957 | 0.75 | GRIK1 (0.50) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL3230 | 0.73 | — | — | |
| D-Aspartate SCHEMBL145539 | 0.73 | — | — | |
| Aspartic Acid SCHEMBL996424 | 0.73 | GRIK1 (0.56) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL11065189 | 0.73 | GRIK1 (0.56) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL1526976 | 0.73 | GRIK1 (0.56) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL3231 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3013964-B1 | COMPOSITIONS FOR INTRODUCING RNA INTO CELLS | ETHRIS GMBH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-7626022-B2 | Racemic mixtures; oxidation; cyclization; crystallization | CHIRACON GMBH (DE) | 2009-12-01 | — | — | US | disclosed |
| US-20050080263-A1 | Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds | CHIRACON GMBH (DE) | 2005-04-14 | — | — | US | disclosed |
| CN-86102923-A | The method for preparing antibiotic derivatives | — | 1986-11-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080263-A1 | Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds | AAAS, ASNS, AADAT | GRIK1 3027/4885GRIK2 1869/4885GRM1 3272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.